Amifostine 82%
112901-68-5
Pharmaceutical Grade
82%
Any China Port
1kg/Papper Bag
2020-01-27
Nicotinamide,Paracetamol,R-Tetrahydropapaverine N-acetyl-L-leucinate R-,Clopidogrel Bisulfate,Cisatracurium Besilate,Dopamine Hydrochloride
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
Amifostine
CAS No.:112901-68-5
Molecular Formula:C5H21N2O6PS
InChIKeys:TXQPXJKRNHJWAX-UHFFFAOYSA-N
Molecular Weight:214.22
Exact Mass:268.085785
UNII:M487QF2F4V
DSSTox ID:DTXSID40150210
NCI Thesaurus Code:C488
HScode:2930909165
Categories:
Characteristics-
PSA:
124
XLogP3:0.64900
Appearance:powder
Density:1.367g/cm3
Boiling Point:441.7°C at 760 mmHg
Flash Point:220.9ºC
Storage Conditions:2-8°C
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H302 Harmful if swallowed
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
Storage none
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Nicotinamide,Paracetamol,R-Tetrahydropapaverine N-acetyl-L-leucinate R-,Clopidogrel Bisulfate,Cisatracurium Besilate,Dopamine Hydrochloride
-
Location:
Chengguan Town, Wuqing District, Tianjin Province, China
-
Payment Terms:
TT against copy of documents,O/A
-
Average lead Time:
10
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
101-200
-
Year of Establishment:
2004
-
Certifications:
China Great Wall (Tianjin) Quality Assurance Center Environment Management System Certification,HALAL,KOSHER,GMP,GMP,GMP,GMP
Tianjin Zhongrui Pharmaceutical co., Ltd. is a professional productive enterprise which dedicates to manufacture pharmaceutical ingredients and intermediates, and established in 2004 with total registered capital of CNY 26 million. The legal representative is Liu Changsuo and chief founders are natural persons from Beijing. Company’s main products include Niacin, Niacinamide , Inositol Nicotinate, Terazosin Hcl, Amifostine, Strontium Renalate, Cisatracurium Besilate, Fasudil Hcl, Clopidogrel hydrogen sulfate, Dopamine Hcl, Febuxostat, etc.
Tianjin Zhongrui serves as an integrated pharmaceutical manufacturer, owning advanced production equipments, "GMP" workshops, and various sophisticated testing instruments. Most company leadership team members are professional and technical with rich experience in pharmaceutical, gaining college degree or above education. The site covers a total area of 21000㎡, of which production workshops 1656 ㎡, QC laboratory 360㎡. Production lines of all raw materials are equipped with special equipments and independent air conditioning system. Our quality control capability is qualified to the production scale. All products pass the GMP certification. Our facility conditions conform to the requirements of the technology, production safety, environmental protection. Internal research institute is equipped with advanced R&D equipments and pilot plant.
Tianijn Zhongrui relies on strong technical force, high-quality work team, perfect quality assurance system to build ourselves as a high-tech enterprise. Therefor the company has achieved rapidly development.
In 2009, Tianjin Zhongrui was identified as high-tech enterprises, and passed the reexamination in 2012. New production technology of Nicotinamide was incorporated into science and technology innovation projects of Tianjin Science and Technology Commission. Strontium Ranelate gets supported by “technology personnel service enterprise action” project of Ministry of Science. The company spent more than CNY3 million on R&D in 2012.
In 2009, in order to introduce the advanced production technology of new drugs and pursue the better development, Tianjin Zhongrui cooperated with a technology-based private institute from Beijing, which is specialized in new drug research and development. This institute invested six new drug’s research achievements and CNY6 million to Tianjin Zhongrui, which injected a huge fresh vitality of science and technology.
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product